Suven Life Sciences Fact Sheet, Suven Life Sciences Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Fact Sheet    (SVNP)


Discover Now: One Stock for Potentially Life-changing Gains


Here is the latest financial fact sheet of Suven Life Sciences. For more details, see the Suven Life Sciences quarterly results and Suven Life Sciences share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN LIFE SCIENCES Price History

Price Rs 99.6
Mkt Cap Rs m 12,677
Vol '000 163.5
P/E X -97.2
P/CF X 11.6
EPS (TTM) Rs -1.0
% ch % 0.3
No. of shares m 127.28
% ch week % -3.3
% ch 1-mth % 26.5
% ch 12-mth % 152.2
52 week H/L Rs 115.8/30.5
(As on May 7, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN LIFE SCIENCES Financials

No. of Mths
Year Ending
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
12
Mar-19
5-Yr Chart
Click to enlarge
SUVEN LIFE SCIENCES EQUITY SHARE DATA
High Rs323339229251338 
Low Rs72144151155169 
Sales per share (Unadj.) Rs40.939.242.749.152.1 
Earnings per share (Unadj.) Rs8.55.66.99.76.8 
Diluted earnings per shareRs8.55.66.89.76.8 
Cash flow per share (Unadj.) Rs9.57.08.511.48.6 
Dividends per share (Unadj.) Rs0.602.001.001.501.50 
Adj. dividends per shareRs0.602.001.001.501.50 
Dividend yield (eoy) %0.30.80.50.70.6 
Book value per share (Unadj.) Rs44.346.852.460.365.3 
Adj. book value per shareRs44.346.852.460.365.3 
Shares outstanding (eoy) m127.28127.28127.28127.28127.28 
Bonus/Rights/Conversions  IS---- 
Price / Sales ratio x4.86.24.44.14.9 
Avg P/E ratio x23.142.827.720.937.1 
P/CF ratio (eoy) x20.834.422.217.829.6 
Price / Book Value ratio x4.55.23.63.43.9 
Dividend payout %7.035.414.615.422.0 
Avg Mkt Cap Rs m25,10030,73224,15825,82532,272 
No. of employees `0000.91.01.01.11.1 
Total wages/salary Rs m365409522613661 
Avg. sales/employee Rs Th5,912.15,236.15,349.75,832.66,132.2 
Avg. wages/employee Rs Th414.4429.1513.5571.5611.1 
Avg. net profit/employee Rs Th1,234.4753.0858.11,153.8803.5 
SUVEN LIFE SCIENCES INCOME DATA
Net Sales Rs m5,2094,9955,4356,2536,635 
Other income Rs m86194211233242 
Total revenues Rs m5,2945,1895,6466,4856,877 
Gross profit Rs m1,5951,0161,2911,9821,604 
Depreciation Rs m118175214213221 
Interest Rs m4759574638 
Profit before tax Rs m1,5169761,2311,9551,587 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m428257359718718 
Profit after tax Rs m1,0887188721,237869 
Gross profit margin %30.620.323.731.724.2 
Effective tax rate %28.226.429.236.745.2 
Net profit margin %20.914.416.019.813.1 
SUVEN LIFE SCIENCES BALANCE SHEET DATA
Current assets Rs m4,4944,2774,9175,6966,232 
Current liabilities Rs m1,1851,1071,1861,2161,490 
Net working cap to sales %63.563.568.671.671.5 
Current ratio x3.83.94.14.74.2 
Inventory Days Days5761628186 
Debtors Days Days2839313683 
Net fixed assets Rs m2,7903,1263,1543,3254,043 
Share capital Rs m127127127127127 
"Free" reserves Rs m5,5105,8266,5437,5478,183 
Net worth Rs m5,6375,9536,6707,6748,310 
Long term debt Rs m5944162592218 
Total assets Rs m7,4567,5158,1579,19210,389 
Interest coverage x33.217.622.743.243.1 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x0.70.70.70.70.6 
Return on assets %15.210.311.414.08.7 
Return on equity %19.312.113.116.110.5 
Return on capital %25.116.218.626.019.5 
Exports to sales %88.187.5000 
Imports to sales %11.612.2000 
Exports (fob) Rs m4,5904,371000 
Imports (cif) Rs m602611000 
Fx inflow Rs m4,7794,6664,9435,0665,622 
Fx outflow Rs m8559421,8572,0011,799 
Net fx Rs m3,9243,7243,0863,0653,822 
SUVEN LIFE SCIENCES CASH FLOW
From Operations Rs m 1,429 675 1,092 699 356 
From Investments Rs m -1,105 -386 -3,107 -6 -279 
From Financial Activity Rs m 1,791 -681 -304 -521 -225 
Net Cashflow Rs m 2,116 -392 -2,319 173 -148 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 36.5%
Shareholders 37,287
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF SDE Serene Chambers, Road No.5, Avenue 7, Banjara Hills, Hyderabad - 500 034
E-MAIL investorservices@suven.com WEB www.suven.com
TELEPHONE (040) 2354 3311 FAX (040) 2354 1152
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Karvy & Company
COMP SEC: K. Hanumantha Rao YEAR OF INC: 1989 BSE CODE: 530239 FV (Rs): 1 DIV YIELD (%): 1.5

Read: SUVEN LIFESCIENCES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   PROCTER & GAMBLE HEALTH  ORCHID PHARMA  GSK PHARMA  TORRENT PHARMA  NOVARTIS  

Compare SUVEN LIFE SCIENCES With:   PROCTER & GAMBLE HEALTH  ORCHID PHARMA  GSK PHARMA  TORRENT PHARMA  NOVARTIS  

Compare SUVEN LIFE SCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS